Which is NOT a challenges for life sciences industry?

Question

Options

• ARising healthcare costs put pressure on cost and favoring generic drugs.
• BThe industry is entering a wave of patent expiration, in which $80 billion in drug revenue comes
• CIncreasing Global Regulatory Compliance pressures delaying new drugs and increasing focus on
• DIncreasing number of employees who are mobile.

• A
  3% (1)
• B
  8% (3)
• C
  6% (2)
• D
  83% (30)

No community discussion yet for this question.